Status:
UNKNOWN
Exercise During Chemotherapy for Patients With Hematological Malignancies
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Hematological Diseases
Hematological Malignancies
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
The trial will evaluate the effects of aerobic exercise in patients undergoing chemotherapy for the treatment of a hematological neoplastic disease.
Eligibility Criteria
Inclusion
- Hematological malignant disease
- Current chemotherapy
- Understanding of written German
Exclusion
- Cardiorespiratory, metabolical, osteoarticular or immunological disorders which can be aggravated by exercise
- Pathological stress-ECG at recruitment
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00884364
Start Date
May 1 2009
End Date
September 1 2011
Last Update
December 23 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Section Sports Medicine, Charité Universitätsmedizin Berlin, Hindenburgdamm 30
Berlin, State of Berlin, Germany, 12200